taurolithocholic acid has been researched along with glucagon in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caldwell, AM; Kolodziej, MP; Zammit, VA | 1 |
| Christian, KG; Hayes, E; Jones, RS; Kortz, WJ; Miller, RJ; Schirmer, BD | 1 |
| Becher, MS; Gerok, W; Kremer, B; Schmidt, K; Schölmerich, J | 1 |
3 other study(ies) available for taurolithocholic acid and glucagon
| Article | Year |
|---|---|
Rapid decrease in the expression of 3-hydroxy-3-methylglutaryl-CoA reductase protein owing to inhibition of its rate of synthesis after Ca2+ mobilization in rat hepatocytes. Inability of taurolithocholate to mimic the effect.
Topics: Animals; Calcimycin; Calcium; Dose-Response Relationship, Drug; Female; Glucagon; Hydroquinones; Hydroxymethylglutaryl CoA Reductases; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kinetics; Liver; Phenylephrine; Rats; Rats, Inbred Strains; Taurolithocholic Acid; Vasopressins | 1991 |
Glucagon lowers canine biliary cholesterol output at physiologic doses.
Topics: Animals; Bile; Bile Acids and Salts; Blood Glucose; Cholesterol; Depression, Chemical; Dogs; Glucagon; Infusions, Parenteral; Insulin; Male; Phospholipids; Portal Vein; Taurolithocholic Acid; Time Factors | 1986 |
[Different effect of taurolithocholate and chenodeoxycholate on structure and function of isolated hepatocytes (author's transl)].
Topics: Animals; Aspartate Aminotransferases; Cell Membrane; Chenodeoxycholic Acid; Cholestasis; Dose-Response Relationship, Drug; Glucagon; L-Lactate Dehydrogenase; Lithocholic Acid; Liver; Microscopy, Electron; Microscopy, Electron, Scanning; Rats; Taurolithocholic Acid; Uric Acid | 1981 |